FDA Approves New Injectable Fillers Restylane Refyne & Restylane Defyne

The FDA has approved two new injectable fillers to be added to the Galderma’s Restylane® family of fillers: Restylane Refyne® & Restylane Defyne®!

Earlier this year, Artemedica’s Dr. Victor Lacombe traveled to Calgary, Canada for Galderma’s Aesthetic Advisory Board Meeting and was one of the first Plastic Surgeons in the United States to inject Restylane Refyne® and Restylane Defyne®. Artemedica will be one of the first practices to begin carrying both products in early 2017.

Restylane Refyne® provides a medium lifting effect. It is commonly used to treat moderate lines and wrinkles. To find out more about Restylane Refyne®, click HERE.

Restylane Defyne® provides a solution for deep wrinkles and folds and replaces lost volume under the skin. To find out more about Restylane Defyne®, click HERE.